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Introduction
Myelinated axons are organized into a series of discrete   domains 
that are distinguishable by their molecular composition and 
physiological function. These domains include the nodes of 
Ranvier, which are enriched in voltage-gated sodium channels 
essential for saltatory conduction, the fl  anking paranodal junc-
tions, and the juxtaparanodes, which are enriched in Shaker 
type K
+ channels (Poliak and Peles, 2003; Salzer, 2003). Each 
of these domains forms as the result of instructive contact-
dependent signals from myelinating glia (i.e., Schwann cells in the 
peripheral nervous system [PNS] and oligodendrocytes in the 
central nervous system). Adhesion molecules on the glial cell 
bind to and recruit a complex of axonal adhesion molecules and 
cytoskeletal proteins; the latter include ankyrin G at the node 
and 4.1B at the paranodes and juxtaparanodes. Interactions with 
these cytoskeletal proteins target and stabilize the localization 
of additional proteins (i.e., sodium channels at the node and 
potassium channels at the juxtaparanodes). However, together, 
these domains (the node, paranodes, and juxtaparanodes) only 
account for  1% of the longitudinal extent of the axon.
The remaining and by far the largest domain of the mye-
linated axon is the internode, the portion of the axon located 
  under the compact myelin sheath. Axons and myelinating glia 
exhibit an intimate functional relationship in this region, as re-
fl  ected in the highly regular apposition of their respective plasma 
membranes, which are separated by 12–13 nm. This separation 
persists after osmotic changes or in various pathologic states 
(Hirano, 1983). Conversely, the periaxonal space as well as 
attachment of the myelin sheath to the axon is disrupted by the 
action of proteases (Yu and Bunge, 1975). These results indicate 
that interactions between the glial and axonal membranes along 
the internode are actively maintained by cell surface proteins.
The molecules that mediate axonal–glial interactions along 
the internode have remained largely elusive. The myelin-associated 
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xon–glial interactions are critical for the induc-
tion of myelination and the domain organization 
of myelinated ﬁ   bers. Although molecular com-
plexes that mediate these interactions in the nodal region 
are known, their counterparts along the internode are 
poorly deﬁ   ned. We report that neurons and Schwann 
cells express distinct sets of nectin-like (Necl) proteins: 
axons highly express Necl-1 and -2, whereas Schwann 
cells express Necl-4 and lower amounts of Necl-2. These 
proteins are strikingly localized to the internode, where 
Necl-1 and -2 on the axon are directly apposed by Necl-4 
on the Schwann cell; all three proteins are also enriched 
at Schmidt-Lanterman incisures. Binding experiments 
demonstrate that the Necl proteins preferentially mediate 
heterophilic rather than homophilic interactions. In particular, 
Necl-1 on axons binds speciﬁ  cally to Necl-4 on Schwann 
cells. Knockdown of Necl-4 by short hairpin RNA inhibits 
Schwann cell differentiation and subsequent myelination 
in cocultures. These results demonstrate a key role for 
Necl-4 in initiating peripheral nervous system myelination 
and implicate the Necl proteins as mediators of axo–glial 
interactions along the internode.
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glycoprotein (MAG), a member of the Ig superfamily expressed 
by myelinating Schwann cells and oligodendrocytes, has been 
specifically localized to this region (Trapp, 1990). MAG is 
expressed in the periaxonal glial membrane at initial stages of 
myelination (Martini and Schachner, 1986) and interacts with sev-
eral axonal components (Hannila et al., 2007); at later stages of 
myelination, it localizes to Schmidt-Lanterman incisures as well 
(Trapp, 1990). However, mice defi  cient in MAG myelinate appro-
priately and exhibit only modest alterations in the periaxonal space 
(Li et al., 1994; Montag et al., 1994), suggesting that other mole-
cules are likely to mediate axo–glial adhesion along the internode.
Recently, a family of adhesion molecules termed the Nectin-
like (Necl) proteins were described (Sakisaka and Takai, 2004). 
Like the nectins, a family of adherens junction proteins, the Necl 
proteins contain three extracellular Ig-like domains, a single trans-
membrane domain, and a short cytoplasmic segment (Fig. 1 A). 
Necl proteins notably differ from the nectins in their cyto-
plasmic sequences, which are linked to the cytoskeleton via a 
FERM (4.1, ezrin, radixin, moesin)-binding domain in their juxta-
membrane region and contain a class II PDZ (PSD-95, DLG, Z01)-
binding sequence at their C terminus. The Necl proteins have 
been implicated in a variety of biological activities, including 
cell adhesion, regulation of cell growth and synaptic function, 
and cell polarity (for review see Ogita and Takai, 2006). They 
were originally identifi  ed as tumor suppressor in lung cancer 1 
(TSLC1)–like proteins, as their limited expression in lung 
cancer cell lines (Gomyo et al., 1999; Fukuhara et al., 2001; 
Kuramochi et al., 2001) and other tumor types (Murakami, 2005) 
correlates with abnormal cell proliferation. They have also been 
shown to promote synapse formation and glutamate receptor 
clustering, leading to an alternative designation as synaptic cell 
adhesion molecules (SynCAMs; Biederer et al., 2002).
Five Necl proteins have been identifi  ed, each independently 
by several groups, which accounts for the diverse nomenclature. 
The Necl proteins include Necl-1/TSLL1/SynCAM3/IgSF4B 
(Fukuhara et al., 2001), Necl-2/TSLC1/SynCAM1/IGSF4/
RA175/SgIGSF (Urase et al., 2001; Ito et al., 2003; Shingai 
et al., 2003), Necl-3/SynCAM2, Necl-4/TSLL2/SynCAM4, and 
Necl-5/Tage4 (Ikeda et al., 2004). As Necl-5 lacks the char-
acteristic FERM- and PDZ-binding motifs of the cytoplasmic 
domain, its classifi  cation as a member of the Necl family is 
controversial (Dong et al., 2006). Necl-2 is the prototype and 
most intensively studied member of this family. It is widely and 
highly expressed, including in the developing nervous system 
and various epithelial tissues (Fukuhara et al., 2001; Urase 
et al., 2001; Fujita et al., 2005). Necl-2 promotes adhesion via 
homophilic (Biederer et al., 2002; Masuda et al., 2002; Shingai 
et al., 2003) and heterophilic interactions (Shingai et al., 2003). 
Like other Necl proteins (Dong et al., 2006; Williams et al., 
2006), Necl-2 is believed to mediate adhesion as a cis-dimer. 
Necl-2 has been reported to interact intracellularly with DAL1, 
a truncated form of the band 4.1B protein (Yageta et al., 2002). 
Other Necl proteins are highly expressed in the nervous system, 
including Necl-1 (Fukuhara et al., 2001; Gruber-Olipitz et al., 
2006) and Necl-4 (Dong et al., 2006). They are inferred to medi-
ate adhesion although their ligands, and their modes of adhesion 
are less well established.
Because of their role in mediating cell adhesion and their 
linkage to 4.1 proteins, including 4.1B, which has been localized 
to the paranodal and juxtaparanodal domains (Ohara et al., 2000; 
Poliak et al., 2001; Denisenko-Nehrbass et al., 2003), we con-
sidered the Necl proteins to be candidates for the mediation of 
axo–glial interactions in one or more of the domains of myelin-
ated fi  bers. We now report that the Necl proteins are localized to 
the internode of myelinated fi  bers in the PNS, that they bind to 
both axons and Schwann cells via heterophilic interactions, and 
that Necl-4 is up-regulated with and essential for myelination. 
These results implicate the Necl proteins as a major new set of 
cell adhesion molecules that mediate and are required for the 
axo–glial interactions along the internode of myelinated axons.
Figure 1.  Expression of Necl proteins by Schwann cells and DRG neurons. 
(A) Schematic organization of the Necl protein family. The extracellular 
segment contains three Ig domains of the variable (V), constant-2 (C2), and 
intermediate (I) types; the cytoplasmic region contains FERM- and PDZ-
binding motifs as indicated. (B) Staining of cultured Schwann cells (left 
column) and of DRG somas and neurites (middle and right columns) with 
antibodies to Necl-1–4 is shown. Schwann cell nuclei are stained in red. 
Antibodies to Necl-1, -3, and -4 recognize the ectodomain of these pro-
teins; the Necl-2 antibody reacts with its C terminus. Necl-1 speciﬁ  cally 
stains neurons, whereas Necl-4 speciﬁ  cally stains Schwann cells. Necl-2 
stains Schwann cell membranes, nuclei, and neurons. Necl-1–3 accumulate 
at sites of contact between the neuronal cell somas. Bars, 50 μm.NECTIN-LIKE PROTEINS MEDIATE AXO–GLIAL INTERACTIONS • MAUREL ET AL. 863
Results
Schwann cells and neurons express 
a different set of Necl proteins
To characterize their expression in axo–glial interactions and 
for use in functional studies, we isolated full-length cDNAs for 
Necl-1–4 by PCR amplifi  cation using Necl sequences present 
in the genomic database. An alignment of the cloned Necl pro-
tein sequences is shown in Fig. S1 A (available at http://www
.jcb.org/cgi/content/full/jcb.200705132/DC1); their schematic 
organization is shown in Fig. 1 A.
To examine the pattern of Necl protein expression in 
Schwann cells, neurons, and peripheral nerves, we used a series 
of antibodies. These included affi  nity-purifi  ed polyclonal anti-
bodies to the C termini of Necl-1 and -2; the latter were previ-
ously reported (Masuda et al., 2002; Surace et al., 2004). Analysis 
demonstrated that these antibodies were of high titer but 
  exhibited some cross-reactivity with the other Necl proteins; 
in particular, both Necl-2 antibodies cross reacted with Necl-3 
(Fig. S2 B, available at http://www.jcb.org/cgi/content/full/jcb
.200705132/DC1), likely as a result of the extensive identity of 
the C termini of these two proteins. To generate specifi  c anti-
bodies to the Necl proteins, we constructed recombinant pro-
teins containing the ectodomain of each Necl protein fused to 
the human Ig Fc domain. These Necl-Fc fusion proteins were 
individually purifi  ed and injected into guinea pigs, resulting in 
the generation of antisera to Necl-1, -3, and -4. Western blotting 
(Fig. S2 B) and immunocytochemistry of permanently trans-
fected CHO cell lines expressing full-length Necl proteins (Fig. 
S2 C) corroborated the specifi  city of each of these antisera. For 
Western blot analysis, detection of the Necl proteins was mark-
edly enhanced by treating lysates with peptide N-glycosidase F 
to remove N-linked oligosaccharides (Fig. S2 A); this likely re-
fl  ects the extensive glycosylation of the Necl protein ectodomain 
(Masuda et al., 2002; Biederer, 2006).
We first analyzed expression of the Necl proteins by 
immunofl  uorescence of Schwann cells and dorsal root ganglion 
(DRG) neurons (Fig. 1 B). Necl-1 was not expressed by Schwann 
cells but was highly expressed at the membranes of DRG 
neuron cell bodies and neurites. Antibodies to the C terminus 
of Necl-2 stained Schwann cell membranes and nuclei and 
robustly stained the membranes of neurites and DRG somas. 
Necl-3 did not stain Schwann cells or neurites, although low 
level Necl-3 expression was detected at the membranes of 
some neuronal somas. The lack of Necl-3 expression on 
Schwann cells and DRG neurites suggests that their staining 
by Necl-2 antibodies refl  ects the bone fi  de expression of Necl-2 
at these sites and is not the result of cross-reactivity with 
Necl-3. Necl-4 was strongly expressed at the membranes of 
Schwann cells, including fi  ne fi  lopodial-like extensions of the 
Schwann cell membrane (unpublished data). No staining of 
neurites or neuronal cell bodies by Necl-4 could be detected. 
These results indicate that neurons and Schwann cells ex-
press quite different sets of Necl proteins: neurites strongly 
express Necl-1 and -2, whereas Schwann cells principally ex-
press Necl-4 and some Necl-2. Interestingly, Necl-1–3 accu-
mulated at sites of contact between neuronal somas in contrast 
to Necl-2 and -4, which were more diffusely expressed by 
Schwann cells.
Western blotting of lysates after deglycosylation confi  rmed 
that Necl-1 is expressed by DRG neurons but not Schwann cells, 
whereas Necl-4 is expressed by Schwann cells but not by DRG 
neurons (Fig. 2 A). Necl-2 was expressed by Schwann cells and 
at substantially higher levels by DRG neurons. Each of these 
proteins (i.e., Necl-1, -2, and -4) accumulated in 21-d-old Schwann 
cell/neuron cocultures, particularly under myelinating conditions. 
These results strongly suggest that expression of the Necl pro-
teins is up-regulated with myelination. We could not detect Necl-3 
expression by Schwann cells and detected only faint expression 
in neurons by Western blotting, which is consistent with the 
immunofl  uorescence data. These latter results further indicate 
that the band recognized by the anti–Necl-2 antibodies in Schwann 
cell and neuronal lysates is indeed Necl-2.
We also examined Necl expression by PCR and Northern 
blot analysis. Northerns confi  rmed the high level expression of 
Necl-4 in sciatic nerves (Fig. 2 B); analysis of developing sciatic 
nerve demonstrated the expression of Necl- 4 mRNA perinatally 
that increased with myelination (Fig. 2 C). PCR analysis confi  rmed 
that Necl-1 and Necl-4 mRNA expression was principally restricted 
to DRG neurons and Schwann cells, respectively (Fig. S3 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200705132/DC1), 
whereas Necl-2 is expressed by both cell types (Fig. S3 B). Modest 
differences in the expression of six previously described Necl-2 
Figure 2.  Necl protein expression and Necl-4 mRNA expression. 
(A) Western blot analysis of Necl protein expression by cultured Schwann 
cells, DRG neurons, and cocultures under nonmyelinating (−) and myelina-
ting (+) conditions. (B) Northern blot analysis of Necl-4 mRNA expression 
in various tissues. (C) Northern blot analysis of Necl-4 mRNA expression 
at different stages of sciatic nerve development.JCB • VOLUME 178 • NUMBER 5 • 2007  864
isoforms, which vary slightly in their ectodomain sequences 
(Biederer, 2006), were also observed by PCR analysis of neuron 
and Schwann cell fi  rst-strand templates (Fig. S3 B).
Necl proteins are localized at the internode 
of myelinated axons
To characterize the distribution of the Necl molecules in mye-
linated fibers, we stained adult mouse teased sciatic nerves. 
Staining demonstrated striking and robust expression of all three 
Necl proteins along the internode (i.e., the region under the 
compact myelin sheath extending into the juxtaparanodal region; 
Fig. 3 A). Necl-1 and -2 are essentially excluded from the 
paranodes (Fig. 3 A, insets), as indicated by the limited overlap 
with the paranodal marker Caspr (Einheber et al., 1997). Necl-4 
is also expressed along the internode and juxtaparanodes but 
could be detected in some paranodes, although at reduced levels. 
None of the Necl proteins were detectable at the node. We were 
unable to detect any specifi  c staining for Necl-3 in the teased 
sciatic nerves (unpublished data). These fi  ndings identify the 
Necl proteins as novel components of the internodal and juxta-
paranodal domains.
Necl-1, -2, and -4 are also expressed at high levels in the 
Schmidt-Lanterman incisures of myelinating Schwann cells 
(Fig. 3 A, arrowheads). Necl-4 was expressed throughout all 
layers of the incisures, whereas Necl-1 and -2 were more vari-
able and were frequently present only in the outermost incisural 
layers. The expression of Necl-1 in the incisures, a Schwann 
cell–specifi  c structure, was unexpected, as Western blots dem-
onstrated no expression of Necl-1 by Schwann cells (Fig. 2 A). 
Therefore, we undertook a developmental Northern analysis of 
Necl-1 in sciatic nerve (Fig. S3, C and D). This confi  rmed that 
Necl-1 mRNA is faintly expressed in sciatic nerve but has a 
Figure 3.  The Necl proteins are localized in the internode and Schmidt-Lanterman incisures. (A) Teased sciatic nerves from adult mice were stained with 
antibodies to Necl-1, -2, or -4 (red) and Caspr (green), a marker of the paranodes. Antibodies to all three Necl proteins stain the internode and Schmidt-
Lanterman incisures (arrowheads). Nodes, which are indicated by asterisks, are shown magniﬁ  ed in the insets without Caspr staining to demonstrate that 
Necl expression is largely excluded from the paranodes. (B) Teased sciatic nerves were double stained for Necl-1 (green) and -4 (red); the merged image 
is shown below. Two nodes and their ﬂ  anking paranodes located in the center of the ﬁ  eld are indicated with asterisks and are unlabeled. (C) A node of 
Ranvier stained for Necl-1 (green) and -4 (red). Both Necl-1 and -4 are largely excluded from the paranodes and node, which is indicated with asterisks. 
(D) An internodal segment of a myelinated nerve shows two incisures (arrowheads) that are stained with antibodies to Necl-1 (green) and -4 (red). In each 
case, Necl-1 expression is restricted to the outer portion of these clefts, whereas Necl-4 stains the entire cleft. (E) A segment of a myelinated nerve stained 
for Necl-4 (red) and MBP (blue) is shown. The arrowhead indicates a Schmidt-Lanterman incisure. (F) Necl-4 (red) colocalizes with MAG (green) along the 
glial internode and in the clefts as shown. Bars (A and B), 25 μm; (C–F) 10 μm.NECTIN-LIKE PROTEINS MEDIATE AXO–GLIAL INTERACTIONS • MAUREL ET AL. 865
delayed onset of expression compared with Necl-4. These 
  results demonstrate that all three of these Necl proteins are 
expressed in the clefts, indicating that Necl-1 and -2 expression 
is up-regulated in Schwann cells with myelination.
Finally, we compared the localization of Necl-1, which is 
enriched on axons, to Necl-4, which is expressed by Schwann 
cells. We stained sciatic nerves with a rabbit polyclonal anti-
body to the C terminus of Necl-1 and the guinea pig antibody to 
Necl-4. These proteins exhibited essentially identical expression 
patterns along the internodal domain (Fig. 3 B, yellow in the 
merged image). An example of a node is shown at higher mag-
nifi  cation in Fig. 3 C. In the incisures, these proteins were fre-
quently but not precisely colocalized; Fig. 3 D illustrates an 
example showing Necl-1 only in the outer layers in contrast to 
Necl-4, which is present throughout all layers. Double staining for 
myelin basic protein (MBP) confi  rmed that Necl-4 (Fig. 3 E, red) 
is localized just internal to the compact myelin sheath (Fig. 3 E, 
blue) adjacent to the axon. The distribution of Necl-4 in the 
periaxonal glial membrane and incisures is similar to that de-
scribed for MAG (Trapp, 1990); double staining confi  rms that 
these proteins indeed colocalize in these domains (Fig. 3 F). 
Collectively, these studies indicate that Necl-1 on the axon is 
directly apposed by Necl-4 on the periaxonal Schwann cell 
membrane in the internodal domain and that the Necl proteins 
are new constituents of the Schmidt-Lanterman clefts.
Necl proteins preferentially mediate 
heterophilic interactions
To analyze their potential function in axo–glial interactions, 
we systematically examined the ability of the Necl proteins to 
Figure 4.  Heterophilic and homophilic interactions of Necl proteins. (A) A representative experiment demonstrating the binding of Necl-Fc constructs to 
monolayers of Necl-1–transfected CHO cells. Staining for the HA epitope on Necl-1 (green) and of the bound Necl proteins (red) is shown. (B) Quantitation 
of the results of binding of individual Necl-Fcs to each Necl-expressing CHO cell line (mean ± SEM [error bars]). The most robust binding is between Necl-1 
and -4. (C) Summary of binding in the Necl family. Binding is scored as no cells (−), <25% (+), 25–50% (++), 50–75% (+++), or 75–100% (++++) 
of cells with bound Necl-Fc. Bar, 50 μm.JCB • VOLUME 178 • NUMBER 5 • 2007  866
mediate homophilic or heterophilic adhesion, focusing on Necl-1, 
-2, and -4, which are expressed in the PNS. Interactions medi-
ated by Necl-3, which is not expressed at detectable levels in the 
PNS, were also examined and are shown in Fig. S4 (available 
at http://www.jcb.org/cgi/content/full/jcb.200705132/DC1). 
To characterize binding within the Necl protein family, we incu-
bated Necl-Fc fusion proteins with monolayers (Fig. 4 A) or 
dissociated cell suspensions of transfected CHO cells expressing 
epitope-tagged Necl proteins (Fig. S4 B). Live staining with an 
anti-HA antibody verifi  ed that the Necl proteins are expressed 
at the surface of the transfected cells (Figs. 4 A and S4) and facili-
tated the isolation of high level expressing cells via FACS. Necl-Fc 
protein binding was monitored with a fl  uorescently labeled 
anti–human Fc antibody. In the case of the dissociated CHO cells, 
this binding was quantitated by FACS analysis; results are sum-
marized in Fig. 4 (B and C).
In general, the Necl proteins preferentially mediate het-
erophilic adhesion. The most robust binding detected was be-
tween Necl-1 and -4; substantial binding of Necl-1 to -2 was 
also observed as previously reported (Shingai et al., 2003). We 
also detected modest homophilic binding by Necl-2 but not by 
Necl-1 or -4. No binding of Necl-Fc proteins to control CHO 
cells (i.e., cells transfected with the empty pcDNA3.1 vector) 
was observed, indicating that Necl-Fc binding to transfected 
cells was specifi  c. As axons express Necl-1 and Schwann cells 
principally express Necl-4, these results suggest that Necl-1 on 
axons binds heterophilically to Necl-4 on Schwann cells.
Necl proteins mediate adhesion to neurons 
and Schwann cells
We next characterized binding of the Necl proteins to purifi  ed 
cultures of DRG neurons and Schwann cells using a similar 
strategy. In general, Necl-2 and -4 bound strongly to DRG neu-
rites, whereas Necl-1 and -2 bound robustly to Schwann cells 
(Fig. 5 A). No binding of Necl-1 to neurons and minimal bind-
ing of Necl-4 to Schwann cells was observed. These fi  ndings 
indicate that the Necl proteins mediate specifi  c adhesion to neu-
rons and Schwann cells.
To test the ability of the Necl proteins to promote direct 
Schwann cell adhesion, we examined Schwann cell attachment 
to Necl-Fc fusion proteins spotted onto plastic dishes at increas-
ing concentrations; human IgG served as a control. The density 
of adherent Schwann cells at each Necl protein site was then 
measured. Representative images are shown in Fig. 5 B, and the 
quantitation of four separate experiments is summarized in Fig. 5 C. 
Schwann cells bound at high density to the substrate-adsorbed 
Necl-1–Fc but not to the Necl-2– or -4–Fc proteins. These results 
confi  rm that Necl-1 is able to promote Schwann cell attachment 
and suggest that it mediates physiologically relevant binding.
Necl-4 expression is required for Schwann 
cell myelination
These results highlight a potential role of the Necl proteins in 
general and of Necl-4 on Schwann cells in particular in the 
axo–glial interactions of PNS myelination. To characterize the 
function of the Necl proteins, we focused on Necl-4, which is 
the major Necl expressed by Schwann cells and is strikingly 
up-regulated with myelination in the cocultures (Fig. 2). For the 
knockdown, we targeted two distinct sequences within the fi  rst 
Ig domain of Necl-4 (Fig. S5 E, available at http://www.jcb.org/
cgi/content/full/jcb.200705132/DC1) and subcloned the corre-
sponding sequences into the pLL3.7 vector (Lois et al., 2002). 
We infected purifi  ed Schwann cells with the lentiviral short 
hairpin RNA (shRNA) constructs; Schwann cells infected with 
the empty pLL3.7 vector or pLL3.7 targeting a nonspecifi  c se-
quence in luciferase (shLuc) served as controls. Both shRNAs 
to Necl-4 resulted in an essentially complete knockdown of 
Necl-4 in Schwann cells (Figs. S5 A and 6 C), whereas Necl-2 
levels were unchanged, underscoring the specifi  city of the 
knockdown. Schwann cells were then added to established neu-
ron cultures and maintained under myelinating conditions for 
an additional 10 d.
Knockdown of Necl-4 in Schwann cells resulted in a strik-
ing inhibition of myelin segment formation compared with 
  control (uninfected) Schwann cells, Schwann cells infected with 
vector alone, or the shRNA to luciferase (Fig. 6 A). Quantitation 
of the number of MBP-positive myelin segments demonstrated 
that the shRNA constructs to Necl-4 signifi  cantly inhibited my-
elination, corresponding to  75% inhibition for shNecl-4 con-
struct #1 (P < 0.001) and essentially complete inhibition with 
the second (shNecl-4 #2) construct (P < 0.001). In a comple-
mentary and independent set of experiments, we also infected 
premyelinating neuron–Schwann cell cocultures with shRNA 
construct #1; myelination was then induced by the addition of 
ascorbate to the culture media. shRNA knockdown again resulted 
in the extensive inhibition of myelination in the cocultures 
(quantitated in Fig. S5 D). In contrast, infection of neurons with 
the Necl-4 shRNA construct before seeding with Schwann cells 
had no effect on myelination in cocultures (unpublished data).
To corroborate the specifi  city of the shRNA effects on 
myelination and to exclude nonspecifi  c off-target effects (for 
review see Cullen, 2006), we performed a knockdown rescue 
experiment. We expressed a modifi  ed Necl-4 protein in Schwann 
cells treated with shRNA (construct #1); this Necl-4 protein 
contained codon substitutions that rendered it insensitive to 
shRNA treatment while preserving its amino acid sequence 
(Fig. S5 E). The modifi  ed Necl-4 protein was robustly expressed 
in shRNA-treated Schwann cells (Fig. 6 C) and, notably, fully 
rescued myelination (Fig. 6 A). These results underscore the 
specifi  city of the shRNA knockdown and confi  rm the crucial 
role of Necl-4 in PNS myelination. Intriguingly, overexpression 
of the Necl-4 construct may enhance myelination in the co-
cultures based on increased numbers of myelin segments (Fig. 6 B). 
These results suggest that Necl-4 may provide a positive signal 
for myelination.
Schwann cells remained associated with axons despite 
the knockdown of Necl-4 based on phase microscopy (unpub-
lished data) and immunofluorescence staining (Fig. S5 F). 
Schwann cell numbers were comparable in the knockdown 
cultures (Hoechst stain; Fig. 6 A). Western blot analysis of the 
effects of Necl-4 knockdown corroborated the inhibition of 
myelin protein expression (Fig. 6 C) and also demonstrated 
substantial effects on Schwann cell transcription factor expression 
(Fig. 6 D). Thus, there was dramatic inhibition of Oct-6, a NECTIN-LIKE PROTEINS MEDIATE AXO–GLIAL INTERACTIONS • MAUREL ET AL. 867
transcription factor expressed by promyelinating Schwann cells 
(Scherer et al., 1994), and nearly complete inhibition of the 
expression of Krox-20, a transcription factor required for the 
myelinating phenotype of Schwann cells (Topilko et al., 1994). 
These results indicate that Necl-4 expression is required for 
progression to the promyelinating stage and subsequent mye-
lination of axons.
Necl-1 on axons mediates binding to Necl-4 
on Schwann cells
Finally, we tested the effects of knockdowns of Necl-1 and -4 
on the binding of Necl proteins to axons and Schwann cells. 
Knockdown of Necl-4 effectively ablated the expression of 
Necl-4 at the Schwann cell membrane (Fig. 7 A, a). In the absence 
of Necl-4, Necl-1 no longer bound to Schwann cells (Fig. 7 A, c). 
Figure 5.  Binding of Necl proteins to DRG neurons and Schwann cells. (A) Conditioned media from nontransfected cells (CM) or cells transfected with indi-
vidual Necl-Fc constructs were incubated with cultures of DRG neurons (top) or Schwann cells (bottom). Bound Fc constructs were visualized with ﬂ  uorescein-
ated anti–human IgG. Necl-1 Fc binds to Schwann cells but not neurons; Necl-4-Fc binds to neurons but not Schwann cells. (B) Representative phase images 
of Schwann cell binding to Necl-Fc proteins. Dissociated Schwann cells were incubated with plastic substrates spotted with human IgG (control) or puriﬁ  ed 
Necl-Fc constructs. (C) Quantitation of the binding of Schwann cells to Necl-Fc constructs spotted onto dishes at the different concentrations indicated (mean ± 
SEM [error bars]). Schwann cells bound robustly only to the Necl-1–Fc substrate. Bars (A), 25 μm; (B) 200 μm.JCB • VOLUME 178 • NUMBER 5 • 2007  868
In contrast, Necl-2 still bound to Schwann cells in the absence 
of Necl-4 (Fig. 7 A, e), indicating that its binding is independent of 
Necl-4. In complementary studies, we performed a knockdown 
of Necl-1 on neurons by lentiviral-mediated shRNA (Fig. 7 B). 
This effectively inhibited Necl-1 expression based on Western 
blotting (Fig. S5 B). In the absence of Necl-1, Necl-4 binding to 
neurites was substantially reduced (Fig. 7 B). Together, these 
results indicate that Necl-1 on the axon and Necl-4 on the 
Schwann cell are obligate binding partners.
Discussion
We have demonstrated that neurons and Schwann cells express 
distinct members of the Necl protein family. We also show that the 
Necl proteins preferentially mediate heterophilic interactions 
(with Necl-1 on the axon binding to Necl-4 on the Schwann cell), 
that these proteins delineate the internodal domain, and that 
Necl-4 mediates axonal–glial interactions required for myelination. 
These results have important implications for the domain orga-
nization of axons and the mechanisms that initiate Schwann cell 
myelination, as considered further below.
Schwann cells and DRG neurons express 
distinct sets of Necl proteins
Previous studies demonstrated that the Necl proteins are ex-
pressed in the nervous system. Necl-1 expression was found 
to be largely restricted to the developing and adult nervous 
  system (Fig. S3, C and D; Fukami et al., 2003; Zhou et al., 2005). 
Necl-2 and -4 are also highly expressed in the nervous system 
(Biederer et al., 2002; Fukami et al., 2002; Fujita et al., 2005) 
Figure 6.  Necl-4 expression is required for Schwann 
cell differentiation and myelination. (A) Representative 
images of myelinating cocultures in which control 
Schwann cells or Schwann cells infected with the lenti-
viral vector alone or lentiviruses encoding shRNA to a 
nonspeciﬁ  c sequence (shLuc) or to Necl-4 sequences, 
in one case rescued with an exogenous Necl-4 protein 
(shNecl-4 #1 + rescue), were added to DRG neurons 
under myelinating conditions. Myelin segments were 
stained for MBP (red) and with the Hoechst nuclear 
dye (blue). (B) Quantitation of the effects of Necl-4 
knockdowns on Schwann cell myelination. Control 
Schwann cells or Schwann cells infected with the lentivi-
ral vector alone or viruses encoding shRNAs to luciferase 
or Necl-4 with or without rescue by an shRNA-resistant 
Necl-4 were seeded onto dissociated DRG neuron cul-
tures and maintained under myelinating conditions for 
10 d. The number of myelin segments that formed 
were quantitated from three separate experiments 
(mean ± SEM [error bars]); controls were normalized 
to 100%. *, P < 0.001. (C) Knockdown of Necl-4 in-
hibits myelin protein expression. Lysates from control 
Schwann cells and cells infected with lentiviruses encod-
ing shRNAs to Necl-4, including cells rescued with a 
modiﬁ  ed Necl-4 protein, were blotted for Necl-4 and 
the myelin proteins MAG and P0; cultures correspond 
to those shown in Fig. 6 A. shRNA treatment effec-
tively knocked down Necl-4 and myelin protein and was 
restored by the overexpression of an shRNA-resistant 
Necl-4. (D) Knockdown of Necl-4 inhibits the expres-
sion of myelin transcription factors. Western blot analy-
sis demonstrates the substantial knockdown of Necl-4 
and corresponding reductions of the transcription factors 
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but are more broadly distributed: Necl-2 is expressed by a variety 
of epithelial tissues, and Necl-4 is highly expressed by the kidney, 
bladder, and prostate (Fig. 2 B; Fukuhara et al., 2001; Williams 
et al., 2006). The primary sites of Necl-3 expression still remain 
to be elucidated.
Our results extend these studies and indicate that neurons 
and Schwann cells express different sets of Necl proteins. Thus, 
DRG neurons preferentially express Necl-1 and -2, whereas 
Schwann cells preferentially express Necl-4 and, at lower levels, 
Necl-2 (Figs. 1 and 2). PCR data also indicate that neurons 
and Schwann cells preferentially express Necl-1 and Necl-4, 
respectively (Fig. S3 A). We were unable to detect the expression 
of Necl-3 on axons, Schwann cells, or sciatic nerve by blotting 
or immunostaining, indicating that Necl-3 is unlikely to con-
tribute to axon–Schwann cell interactions. Low levels of Necl-3 
were present at sites of contact between neuronal cell bodies.
Heterophilic interactions between Necl-1 
and -4 mediate axon–Schwann 
cell interactions
We systematically characterized all potential interactions within 
the Necl family (Figs. 4 and S4), substantially extending pre-
vious analyses. Our data demonstrate that the Necl proteins 
preferentially mediate heterophilic rather than homophilic inter-
actions. The strongest interactors among the three Necl proteins 
expressed in the PNS are Necl-1 with Necl-4. Necl-1 also 
strongly binds to Necl-2, consistent with the accumulation of 
both of these proteins at sites of neuronal contact (Fig. 1 B). 
Homophilic interactions of Necl-2 were detected (Fig. 4) as pre-
viously reported (Biederer et al., 2002; Masuda et al., 2002) but 
were less robust. We were unable to detect homophilic adhesion 
mediated by Necl-1 or by Necl-4; the former result contrasts 
with recent studies (Kakunaga et al., 2005; Dong et al., 2006). 
Thus, Necl-1 and -4 likely function physiologically as hetero-
philic adhesion molecules.
An interaction of axonal Necl-1 with Schwann cell Necl-4 
is strongly supported by several lines of evidence. Necl-1 and -2 
are localized along the internodal axon in a pattern that is es-
sentially identical to that of Necl-4 on the apposed Schwann 
cell membrane (Fig. 3 B). However, although axons express 
both Necl-1 and -2, Schwann cells only attached to substrates 
patterned by the Necl-1–Fc protein (Fig. 5). Knockdown of 
Necl-4 abolished Necl-1 but not Necl-2 binding to Schwann 
cells; similarly, knockdown of Necl-1 abolished the binding of 
Necl-4 to axons (Fig. 7). These latter results confi  rm that Necl-1 
on axons binds specifi  cally to Necl-4 on Schwann cells and sug-
gest that the low level expression of Necl-2 on Schwann cells 
does not contribute appreciably to Necl-1 adhesion.
As noted, Necl-2 is also expressed at high levels along the 
internode (Fig. 3 A). Although both neurons and Schwann cells 
are potential sources of Necl-2 along the internode, immuno-
staining of cultured cells suggests that this expression is largely 
neuronal (Fig. 1 B). Preliminary immuno-EM with a Necl-2 anti-
body further suggests that neurons are an important source of 
Necl-2 expression in the internode but also confi  rms the high 
level expression of Necl-2 in the Schmidt-Lanterman incisures 
(unpublished data). As Necl-2 binds to Schwann cells in a Necl-4–
independent manner, its ligand on the Schwann cells remains 
to be determined. Necl-2 may bind via weak homophilic inter-
actions to Schwann cells, where it is also expressed at reduced 
levels (Figs. 1 B and 2 A). However, clustering of the Necl-2–Fc 
bound to Schwann cells recruits only limited amounts of en-
dogenous Necl-2 (not depicted), and Necl-2 does not accumu-
late at sites of contact between Schwann cells (Fig. 1 B). Thus, 
Necl-2 may bind to Schwann cells by a Necl-independent 
mechanism. Necl-2 has several known heterophilic ligands, 
Figure 7.  Necl-4 on Schwann cells binds to Necl-1 on axons. (A) Schwann cells were infected with a dilution of the lentivirus encoding shRNA (construct 
#1) to Necl-4. Effects of shRNA treatment on Necl-4 expression (a) and the binding of Necl-1–Fc (c) and Necl-2–Fc (e); corresponding ﬁ  elds shown below 
(b, d, and f) are stained for GFP to identify infected cells. Examples of infected cells are outlined by dashed white lines. (B) Necl-4–Fc does not bind to axons 
in the absence of Necl-1. shRNA-treated neurons were incubated with Necl-4–Fc; robust binding is seen in control but not shRNA-treated neurites. The cor-
responding Western blot is shown in Fig. S5 C (available at http://www.jcb.org/cgi/content/full/jcb.200705132/DC1). Bottom panels show the same 
ﬁ  elds stained for neuroﬁ  lament. Bars (A), 25 μM; (B) 40 μm.JCB • VOLUME 178 • NUMBER 5 • 2007  870
 including  Nectin-3  (Shingai et al., 2003) and the class I major 
histocompatibility complex–restricted T cell–associated mole-
cule, an Ig cell adhesion molecule expressed on activated T 
cells (Arase et al., 2005; Boles et al., 2005). Whether either of 
these ligands is expressed by Schwann cells and mediates bind-
ing to Necl-2 on axons will require additional investigation. 
Collectively, our results suggest that Necl-1 and Necl-2 on the 
axon bind to Schwann cells via Necl-4 and via an as yet un-
known Schwann cell receptor, respectively. The expression and 
putative trans-interactions of Necl proteins in the internode are 
summarized in Fig. 8.
Necl protein complexes delineate 
the internodal domain and 
Schmidt-Lanterman incisures
With the identifi  cation of the Necl proteins as mediators of 
axon–glial interactions in the internode, key adhesion com-
plexes in each of the domains of myelinated axons have now 
been identifi  ed. Thus, like other domains of myelinated axons 
(Poliak and Peles, 2003; Salzer, 2003; Schafer and Rasband, 
2006), the internode contains a specifi  c set of glial cell adhesion 
molecules that bind to cognate adhesion molecules on the axon. 
In addition to their expression in the internode, the Necl pro-
teins are also present in the juxtaparanodes, where they are likely 
to supplement the axo–glial interactions mediated by TAG-1 
and Caspr2 (Poliak et al., 2003; Traka et al., 2003). The Necl 
proteins are largely excluded from the paranodes (Fig. 3), al-
though Necl-4 expression does extend into some glial paranodes 
at modest levels.
The Schmidt-Lanterman clefts are the other major site of 
Necl expression in mature myelinated nerves (Fig. 3 A). Necl-1 
and -2 are highly expressed together with Necl-4 in this 
Schwann cell–specifi  c site; their localization at this site, together 
with epithelial cadherin (E-cadherin; Fannon et al., 1995) and 
MAG (Fig. 3 F), presumably contributes to organization of the 
incisures. Binding preferences suggest interactions of Necl-1 
with -4 and Necl-1 with -2 at this site (Fig. 8). The precise 
nature of the interactions remains to be established, as Necl-1 
and -4 do not consistently colocalize in all layers of the clefts 
(Fig. 3 D). Accumulation of the Necl proteins in the clefts may 
also contribute to the increased expression that occurs during 
myelination, as detected by Western blotting of the cocultures 
(Fig. 2 A). The presence of Necl-1 in the clefts also indicates 
that it is not strictly neuron specific but rather that it is up-
regulated in Schwann cells with myelination; the latter find-
ing was confi  rmed by Northern blots of developing sciatic 
nerve (Fig. S3 D).
The presence of the Necl proteins along the internode and 
in the clefts further suggests several candidate proteins with 
which they may interact at these sites. The Necl proteins con-
tain a conserved FERM-binding domain in their cytoplasmic 
sequence and have been reported to interact biochemically with 
the members of the 4.1 protein family, including Necl-1 with 
4.1N (Zhou et al., 2005) and Necl-2/TSLC1 with a truncated 
form of 4.1B (Yageta et al., 2002). In agreement, we have iden-
tifi  ed 4.1 proteins along the internode and in the clefts (unpub-
lished data). The Necl proteins also contain a class II PDZ 
domain–binding motif at their C terminus that mediates their 
interactions with membrane-associated guanylate kinase family 
members. Necl-1 and -2 can interact with PDZ domain proteins 
CASK (Biederer et al., 2002; Kakunaga et al., 2005), PASL2 
(Shingai et al., 2003), and Dlg3 (Kakunaga et al., 2005). A vari-
ety of membrane-associated guanylate kinase proteins are 
known to be concentrated in the incisures (Poliak et al., 2002) 
and, therefore, are candidates to interact with the C terminus of 
the Necl proteins. Finally, we note that MAG is coexpressed 
with Necl-4 at high levels in the glial periaxonal membrane in 
the internode and in the clefts. Whether MAG interacts either in 
cis (i.e., with Necl-4) or in trans (i.e., with Necl-1 or -2) is not 
yet known.
Figure 8.  Summary of Necl protein inter-
actions within domains of myelinated ﬁ  bers. 
Schematic diagram showing the domain orga-
nization of a myelinated axon and the poten-
tial interactions between the Necl proteins in 
the internode and Schmidt-Lanterman incisures. 
In the internode and juxtaparanodes (JPN), 
Necl-1 on the axon binds to Necl-4 on the 
Schwann cell. Necl-2 is also present on the 
axon; its interacting partners on the Schwann 
cell are not yet known. The Necl proteins are 
also heavily expressed in the Schmidt-Lanterman 
incisures of mature myelinated nerves; Necl-1 
and -2 are expressed primarily in the outer 
portions of the clefts (indicated), whereas Necl-4 
is expressed in all layers. Potential interactions 
in the clefts of Necl-1 with Necl-4 and -2 and 
homophilic interactions of Necl-2 are illustrated. 
There is essentially no expression of the Necl 
proteins in the paranodal junctions (PNJ) or at 
the node. Necl proteins are shown as cis-dimers 
predicted from structural data.NECTIN-LIKE PROTEINS MEDIATE AXO–GLIAL INTERACTIONS • MAUREL ET AL. 871
Necl-4 is essential for myelination
A key fi  nding of this study is that Necl-4 has an essential role in 
the initial axo–glial interactions required for myelination. Knock-
down of Necl-4 (Figs. 6 and S5) effi  ciently blocks Schwann cell 
differentiation and myelination, as indicated by the absence of 
myelin proteins and myelin segments. The limited expression of 
Oct-6 and Krox-20 in the knockdown cocultures indicates that 
Schwann cells are arrested before progressing to the promyelin-
ating stage. Thus, Necl-4 is critical for axonal signaling that 
drives Schwann cell differentiation and myelination.
A key question is how Necl-4 mediates these effects. One 
possibility is that in the absence of Necl-4, axon–Schwann cell 
apposition and interactions are impaired, preventing effective 
signaling from the axon. A major axonal signal for myelination 
is type III neuregulin 1, which is required for Schwann cell dif-
ferentiation and regulates myelin sheath thickness (Michailov 
et al., 2004; Taveggia et al., 2005). Initial results demonstrate that 
Necl-4–defi  cient Schwann cells still attach to and amplify in 
association with axons (Fig. S5 F), which is in contrast to the 
aberrant interactions Schwann cells display with neuregulin-
defi  cient axons (Taveggia et al., 2005). Although preliminary, 
these results suggest that other adhesion molecules can promote 
the attachment of Schwann cells to the axon (Wanner and Wood, 
2002) and that Necl-4 may have a distinct role in promoting 
Schwann cell differentiation and myelination. Of potential in-
terest, the Necl proteins have been implicated in promoting cell 
polarity (for review see Ogita and Takai, 2006), which is a critical 
early event required for the initiation of Schwann cell myelina-
tion (Chan et al., 2006; Taveggia and Salzer, 2007). Whether 
Necl-4 interacts with components of the polarity complex im-
plicated in myelination (Chan et al., 2006), as suggested by its 
localization at the inner glial turn and its PDZ-binding sequences, 
will be of interest for future study.
In summary, these fi  ndings suggest that Necl-4 has several 
key roles in axo–glial interactions: a crucial role in promoting 
Schwann cell differentiation and myelination, a potentially related 
role in organizing the internodal domain by binding to Necl-1 on 
the axon, and an additional role with Necl-1 and -2 in organizing 
the Schmidt-Lanterman incisures. Elucidating the events down-
stream of Necl-4 signaling and its potential role in central nervous 
system myelination are likely to provide important additional in-
sights into the axo–glial signaling of myelination.
Materials and methods
Isolation of cDNAs for Necl proteins
Total RNA was isolated from puriﬁ  ed rat Schwann cells or rat DRG neurons 
with the RNAqueous-4PCR kit (Ambion); mRNA from mouse brain was puri-
ﬁ  ed using the mRNA isolation kit (Roche). First-strand templates were pre-
pared by RT-PCR with an oligo-dT primer (Promega). cDNAs for Necl-1–4 
were ampliﬁ  ed using primers based on rodent sequences and cloned into 
the pcDNA3.1 directional TOPO cloning vector (Invitrogen).
To clone the rat Necl-1, sense (A  T  G  G  G  G  G  C  C  C  C  T  T  C  C  G  C  C  C  T  ) and 
antisense (C  T  A  G  A  T  G  A  A  A  T  A  T  T  C  C  T  T  C  T  T  G  T  C  A  T  C  C  C  C  G  C  C  ) primers were 
used to PCR amplify a full-length cDNA from rat DRG neuron ﬁ  rst strand 
(GenBank/EMBL/DDBJ accession no. DQ272743). To clone Necl-2, we 
designed primers based on the mouse cDNA for TSLC1 (Fukami et al., 
2002). We ampliﬁ  ed a full-length cDNA from adult mouse brain with sense 
(A  T  G  G  C  G  A  G  T  G  C  T  G  T  G  C  T  G  C  C  ) and antisense (C  T  A  G  A  A  G  T  A  C  T  C  T  T  T  C  T  T-
T  T  C  T  T  C  G  G  A  G  T  T  ) primers. This mouse isoform of Necl-2 corresponds to 
isoform 4 of SynCAM 1 (Biederer et al., 2002) that lacks the putative mucin-
like domain of the predicted rat sequence. The mouse Necl-2 cDNA is 
available from GenBank/EMBL/DDBJ (accession no. DQ279856). Necl-3 
was ampliﬁ  ed from rat Schwann cell ﬁ  rst strand using sense (A  T  G  A  T  T  T  G  G-
A  A  A  C  G  C  A  G  ) and antisense (TTAAATGAAA  T  A  C  T  C  T  T  T  T  T  T  C  T  C  ) primers, 
and the sequence is available from GenBank/EMBL/DDBJ (accession no. 
DQ272744). A full-length Necl-4 cDNA was ampliﬁ  ed from rat Schwann 
cell ﬁ  rst strand using sense (A  T  G  G  G  C  C  G  G  G  C  C  C  G  G  C  G  C  T  T  C  C  ) and anti-
sense (A  A  T  G  A  A  G  A  A  T  T  C  T  T  C  T  T  T  C  C  G  T  T  T  G  T  G  T  C  C  A  T  C  G  C  C  G  C  ) primers, 
and the sequence is available from GenBank/EMBL/DDBJ (accession 
no. DQ272745).
Generation of permanently transfected CHO cell lines expressing 
Necl proteins
CHO cells were transfected with full-length constructs for each Necl protein 
and with the empty pcDNA3.1 vector using the LipofectAMINE 2000 reagent 
(Invitrogen); permanently transfected cells were selected by maintenance in 
G418-containing medium (α-MEM, 10% FBS, and 750 μg/ml G418). To fa-
cilitate analysis, the sequence encoding the inﬂ  uenza HA epitope was added 
by PCR to the N terminus of each Necl protein immediately after the signal 
peptide as predicted by the SignalP program. CHO cells were stained for the 
HA epitope and selected by FACS (MoFlo; DakoCytomation).
Generation of Necl-Fc fusion proteins
Constructs encoding the extracellular domain of each Necl protein fused to 
the hinge region of the human IgG-Fc were subcloned into the pcDNA 3.1 
TOPO vector (Invitrogen) and transiently transfected into HEK 293FT cells 
(Invitrogen). Transfected cells were maintained in media containing DME, 
1% Ultra Low IgG FBS (Invitrogen), 1 mM nonessential amino acids (Invit-
rogen), and 2 mM L-glutamine. Conditioned media was collected after 3 d 
and alkalinized by 1 M Hepes buffer (Invitrogen) at 10% vol, and the salt 
concentration was increased by adding 10× Dulbecco’s PBS (dPBS) at 
25% vol. The conditioned media was then ﬁ  ltered, and Necl-Fc proteins 
were collected batchwise with protein A–agarose beads (Roche). The beads 
were washed with 6× dPBS plus 0.2% Triton X-100 (Sigma-Aldrich) followed 
by 6× dPBS and 1× dPBS washes. The proteins were eluted off the beads 
with 200 mM glycine buffer at pH 2.8, immediately neutralized with 1 M 
Hepes, pH 8.5, at 10% vol, and dialyzed overnight against dPBS (1:500 
vol/vol) using Slide-A-Lyser dialysis cassettes (Pierce Chemical Co.). Protein 
concentrations were assessed with the BCA Protein Assay (Pierce Chemical 
Co.). Biochemical analysis conﬁ  rmed that each construct encoded proteins 
of the predicted size of  65 kD after deglycosylation.
Antibodies and immunoﬂ  uorescence
Guinea pig polyclonal antibodies were generated against Necl-1, -3, and 
-4 by immunization with the corresponding Necl-Fc fusion protein. Antibodies 
to the human Fc moiety were removed by passing antiserum over an 
agarose–human IgG (Jackson ImmunoResearch Laboratories) column. 
Rabbit polyclonal antibodies to Necl-2 have previously been described 
(Masuda et al., 2002; Surace et al., 2004). A rabbit polyclonal antibody 
was raised to the C-terminal sequence (A  E  G  G  Q  S  G  G  D  D  K  K  E  Y  F  I  ) of Necl-1 
coupled to keyhole limpet hemocyanin and injected into rabbits, and the 
resulting antibodies were afﬁ  nity puriﬁ  ed against the immunizing peptide 
coupled to Sepharose beads. Other antibodies included mouse monoclo-
nal antibodies to MBP (SMI-94) and neuroﬁ  lament (SMI-31 and SMI-32; all 
obtained from Sternberger Monoclonals) and the HA epitope (HA.11; Co-
vance). Polyclonal antibodies speciﬁ  c to Krox-20 and Oct-6 (provided by 
D. Meijer, Erasmus University, Rotterdam, Netherlands), Caspr (gifts from 
E. Peles [Weizmann Institute, Rehovot, Israel] and M. Bhat [University of 
North Carolina, Chapel Hill, NC]), MAG (Pedraza et al., 1990), and neuro-
ﬁ  lament (Covance) were also used. Secondary antibodies included donkey 
anti–mouse (FITC, rhodamine X, Cy5, and amino-methylcoumarin conju-
gated), donkey anti–guinea pig (FITC and rhodamine X conjugated), donkey 
anti–rabbit (FITC and rhodamine X conjugated), donkey anti–chicken (Cy5 
and amino-methylcoumarin conjugated), and goat anti–human-Fc (FITC 
and rhodamine X conjugated; Jackson ImmunoResearch Laboratories). For 
FACS analysis, we also used phycoerythrin (PE)-conjugated donkey anti–
mouse (eBioscience).
Immunoﬂ  uorescent preparations were examined by epiﬂ  uorescence 
on a confocal microscope (LSM 510; Carl Zeiss MicroImaging, Inc.). Con-
focal images were acquired with Neoﬂ  uor 40× NA 1.3 oil or Apochromat 
63× NA 1.4 oil objectives (Carl Zeiss MicroImaging, Inc.) on an 8-bit 
photomultiplier tube (Carl Zeiss MicroImaging, Inc.) using LSM software 
(Carl Zeiss MicroImaging, Inc.). In some cases, brightness and contrast 
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Neuron and Schwann cell cultures
Establishment of primary rat Schwann cell and DRG neuron cultures has 
been described previously (Einheber et al., 1993). In brief, neurons were 
isolated from embryonic day 16 DRGs by trypsinization and plated on a 
collagen substrate (Biomedical Technologies Inc.) in standard neuronal 
medium (neurobasal medium, 2% B27 supplement, 2 mM L-glutamine, 0.4% 
glucose, and 50 ng/ml 2.5S NGF). Nonneuronal cells were removed by 
feeding the cultures every 2 d alternately with standard neuronal medium 
supplemented or not supplemented with 5-ﬂ  uorodeoxyuridine and uridine 
(both at 10 μM) over a week. Schwann cells prepared from postnatal day 
2 sciatic nerves (Brockes et al., 1979) were expanded in D media (DME, 
10% FBS, and 2 mM L-glutamine) supplemented with 4 μM forskolin and 
5 ng/ml of the EGF domain of rhNRG-1-β1 (over a period of 2–3 wk; R&D 
Systems). Schwann cells were then maintained in D media for 3 d before 
use. Myelinating Schwann cell–neuron cocultures were established by 
seeding puriﬁ  ed DRG neuron cultures with 200,000 Schwann cells in C media 
(MEM, 10% FBS, 2 mM L-glutamine, 0.4% glucose, and 50 ng/ml 2.5S 
NGF). After 3 d, cocultures were supplemented with 50 μg/ml ascorbic 
acid to initiate basal lamina formation and myelination and were maintained 
for an additional 10–21 d.
DME was obtained from BioWhittaker Bioproducts. α-MEM, MEM, 
neurobasal media, B27 supplement, L-glutamine, trypsin, and G418 were 
purchased from Life Technologies. Glucose, forskolin, 5-ﬂ  uorodeoxyuridine, 
uridine, and ascorbic acid were purchased from Sigma-Aldrich. FBS was 
obtained from Gemini, and NGF was purchased from Harlan Bioproducts.
Preparation of teased sciatic nerves
Sciatic nerves were removed from 10–12-mo-old C57BL mice, ﬁ  xed with 
4% PFA (Electron Microscopy Sciences) for 2 h, and stored in dPBS (Invitrogen) 
at 4°C until teased. Teased sciatic nerve ﬁ  bers were mounted on glass 
slides, dried overnight at room temperature, and stored at −80°C until use 
for immunoﬂ  uorescence staining.
Necl binding and FACS analysis
To analyze the binding of Necl proteins to Schwann cells, DRG neurons, and 
CHO-Necl clones, cells were rinsed with L15 medium (Invitrogen) and incu-
bated for 45 min at RT with conditioned media from transiently transfected 
HEK 293FT cells secreting speciﬁ  c Necl-Fcs. Cultures were washed once 
with L15 and incubated with a FITC- or rhodamine X–conjugated goat anti–
human Fc for 45 min at room temperature. After washing with dPBS, cultures 
were ﬁ  xed with 4% PFA. Schwann cells and CHO-Necl clones were mounted 
in the presence of Hoechst dye (Invitrogen) nuclear stain. DRG neurons were 
further stained for neuroﬁ  laments before mounting.
To further characterize homophilic versus heterophilic Necl binding, 
we performed a FACS analysis with Necl-Fc constructs. CHO cells ex-
pressing Necl proteins were brieﬂ  y trypsinized for 1 min with 0.125% 
trypsin and 0.5 mM EDTA at room temperature, collected in ice-cold HBSS 
medium (Invitrogen) containing 10% FBS to terminate trypsinization, and 
washed twice in HBSS medium. Cells were diluted in HBSS to a ﬁ  nal con-
centration of 750,000 cells in 200 μl and incubated with either one of 
the Necl-Fc proteins or whole human IgG at a ﬁ  nal concentration of 200 nM; 
cells were incubated on ice for 30 min. Anti-HA antibody at 1:500 was 
also added to detect the CHO-Necl cells. After incubation, cells were 
washed once with ice-cold HBSS and incubated with PE-conjugated don-
key anti–mouse (to detect expressing cells) and FITC-conjugated anti–
human Fc (to detect Necl-Fc binding; both at 1:100) for 30 min on ice. 
After two washes in ice-cold HBSS and one wash in Ca
2+/Mg2
+-free ice-
cold dPBS, ﬂ  uorescence measurements of individual cells were performed 
using FACS (FACScan; Becton Dickinson). Log ﬂ  uorescence was collected 
for FITC (channel FL1-H) and PE (channel FL2-H) and displayed as double-
parameter (PE/FITC) graphs. For each CHO-Necl clone, the FL2-H chan-
nel was calibrated by labeling cells for the HA tag only (no FITC), whereas 
the FITC channel (no PE) was calibrated by detecting Necl-Fc, giving the 
strongest binding as determined initially by binding to cells in culture. Ad-
ditional controls included omitting anti-HA antibodies and Necl-Fc pro-
teins, with only PE- and FITC-conjugated secondary antibodies added. 
Analysis was ﬁ  rst gated on single cells on the basis of forward and side 
light scatter based on data acquisition from 10,000 cells. Each CHO-
Necl clone was incubated with human IgG as a control. The FITC ﬂ  uores-
cence value below which 99% of the events were found was noted and 
used as the boundary between no binding versus binding (Fig. S4 B, left 
and right red boxes). Binding of Necl-Fc was determined by counting the 
number of cells in the binding gate and dividing by the total number of 
cells. FACS analysis was performed with the FlowJo software package 
(Tree Star, Inc.).
Cell adhesion assay
Necl-Fc proteins serially diluted in HBSS were spotted (2 μl/spot) onto 
100-mm nontissue culture polystyrene dishes (Fisherbrand; Fisher Scientiﬁ  c) 
to minimize nonspeciﬁ  c cell attachment to the plastic. Duplicate spots were 
made for each dilution of Necl-Fc per experiment. Plates were incubated in 
a 37°C tissue culture incubator for 1 h, washed twice with HBSS, blocked 
with 1% BSA in HBSS for 1 h at 37°C, washed twice with HBSS, and 
washed once with D media. Schwann cells were brieﬂ  y trypsinized, re-
suspended in D media at a density of 250,000 cells/ml, and 10 ml were 
added to each plate. The cultures were incubated in a 10% CO2 and 37°C 
tissue culture incubator for 90 min. The plates were then gently washed 
with dPBS twice, and cells were ﬁ  xed with 4% PFA. Phase-contrast digital 
images of the spots (10× ﬁ  elds) were captured with a microscope (Eclipse 
TE2000-U; Nikon), and the number of cells per ﬁ  eld was determined using 
ImageJ software (National Institutes of Health).
RNAi of Necl proteins
To generate shRNAs, we used the pLentiLox (pLL3.7) vector in which the U6 
promoter drives shRNA expression and GFP is expressed under separate 
promoter control (provided by L. Van Parijs; Rubinson et al., 2003; Dillon 
et al., 2005). Two 21 nucleotide shRNAs (#1: nt 79–99, G  T  G  C  A  G  A  C  A  G-
A  G  A  A  T  G  T  G  A  C  G  ; #2: nt 151–171, G  G  G  T  C  T  A  T  A  G  T  C  G  T  C  A  T  T  C  A  G  ) that 
targeted sequences within the ﬁ  rst IgG domain of Necl-4 were designed 
using Easy siRNA (ProteinLounge), BLOCK-iT RNAi designer (Invitrogen), 
and siRNA sequence selector (CLONTECH Laboratories, Inc.). The shRNA 
stem loops for pLL3.7 vector were designed to contain a sense shRNA se-
quence followed by a short (9 nt) nonspeciﬁ  c loop sequence and an anti-
sense shRNA sequence followed by six thymidines, which serve as a stop 
signal for RNA polymerase III. The 5′-phosphorylated PAGE-puriﬁ  ed oligo-
nucleotides were annealed and subcloned into HpaI–XhoI sites of pLL3.7. 
The lentiviral vector was transfected into 293FT cells together with packag-
ing plasmids ∆8.9 and pCMV-VSVG (provided by J. Milbrandt, Washington 
University, St. Louis, MO) using LipofectAMINE 2000 (Invitrogen). As controls, 
we used the empty pLL3.7 vector or a vector encoding shRNA to a non-
speciﬁ  c (luciferase) sequence. Viral supernatants were collected 72 h after 
transfection, centrifuged at 3,000 rpm for 15 min, aliquoted for one-time use, 
and frozen at −80°C. An shRNA targeting a 21-nt sequence (nt 733–753; 
G  T  G  C  A  G  A  C  A  G  A  G  A  A  T  G  T  G  A  C  G  ) in the third IgG domain of Necl-1 was 
designed using the same approach.
For rescue experiments, a codon-modiﬁ  ed Necl-4 construct was gen-
erated using the QuikChange XL Site-Directed Mutagenesis kit (Stratagene). 
The sequence G  T  G  C  A  G  A  C  A  G  A  G  A  A  T  G  T  G  A  C  G   (nt 79–99) was replaced 
with sequence G  T  A  C  A  A  A  C  G  G  A  A  A  A  C  G  T  A  A  C  A  , which did not change 
the amino acid composition of Necl-4 but rendered the construct insensitive 
to the Necl-4–speciﬁ  c shRNA #1. The modiﬁ  ed Necl-4 was subcloned into 
the pLenti6/V5 Directional Topo vector (Invitrogen), and viral production 
was performed as per the pLL3.7 constructs.
Freshly plated Schwann cells (10
6 cells per 100-mm plate) were 
incubated for 3 d with viruses at a 2/3 dilution (vol/vol) in D media (DME, 
10% FBS, and 2 mM L-glutamine) supplemented with forskolin and rhNRG-
β1 (EGF domain). Cells were expanded for an additional week and main-
tained for 3 d in D media before use. Protein knockdowns were conﬁ  rmed 
by Western blotting and by immunohistochemistry.
Northern blot analysis
RNA was isolated from rat sciatic nerves and Schwann cells by CsCl2 gra-
dient centrifugation (Chirgwin et al., 1979). Equal amounts (10 μg) of total 
RNA were electrophoresed in 1% agarose and 2.2 M formaldehyde gels, 
transferred to nylon membranes (Duralon; Stratagene) in 6× SSC, and UV 
cross-linked (0.12 J). Blots were prehybridized, hybridized, and washed 
using standard techniques; the ﬁ  nal stringency of the wash was 0.2× SSC 
at 65°C for 30 min (Sambrook et al., 1989). cDNAs corresponding to 
nt 1–981 of rat Necl-1 and nt 1–966 of rat Necl-4 were used as probes. 
The probes were generated by PCR, isolated by agarose gel electrophoresis, 
and puriﬁ  ed with the QIAquick Gel Extraction kit (QIAGEN). 
32P-labeled 
cDNA probes with speciﬁ  c activities of 2–5 × 10
9 cpm/μg were prepared by 
primer extension with random hexamers using the Prim-a-gene kit (Promega) 
according to the manufacturer’s instructions
Software
Sequence alignments were performed with the Clustal V program (Higgins, 
1994). The Necl proteins were analyzed for the presence of putative 
domains using the following programs and databases: SignalP (Nielsen 
et al., 1997) and TMHHM (Nielsen and Krogh, 1998), Pfam (Bateman 
et al., 2004), SMART (Schultz et al., 1998), and Scansite 2.0 (Obenauer NECTIN-LIKE PROTEINS MEDIATE AXO–GLIAL INTERACTIONS • MAUREL ET AL. 873
et al., 2003). Statistical analysis was performed with the Prism software 
package (GraphPad).
Online supplemental material
Fig. S1 presents amino acid sequences of the Necl proteins. Fig. S2 shows 
Necl expression CHO cell lines and speciﬁ   city of anti-Necl antibodies. 
Fig. S3 shows PCR of Necl-2 isoforms and Northern analysis of Necl-1. 
Fig. S4 presents the binding of Necl-Fc fusion proteins to Necl-expressing 
cells. Fig. S5 shows that the knockdown of Necl-4 inhibits myelination in 
cocultures. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200705132/DC1.
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